- Home
- PEPG vs CCEL Comparison
PEPG vs CCEL Comparison
Compare PEPG & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- CCEL
- Stock Information
- Founded
- PEPG 2018
- CCEL 1989
- Country
- PEPG United States
- CCEL United States
- Employees
- PEPG N/A
- CCEL N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- CCEL Managed Health Care
- Sector
- PEPG Health Care
- CCEL Health Care
- Exchange
- PEPG Nasdaq
- CCEL Nasdaq
- Market Cap
- PEPG 43.2M
- CCEL 39.9M
- IPO Year
- PEPG 2022
- CCEL 1997
- Fundamental
- Price
- PEPG $1.29
- CCEL $4.48
- Analyst Decision
- PEPG Buy
- CCEL Strong Buy
- Analyst Count
- PEPG 3
- CCEL 1
- Target Price
- PEPG $7.67
- CCEL $8.50
- AVG Volume (30 Days)
- PEPG 311.5K
- CCEL 8.6K
- Earning Date
- PEPG 08-07-2025
- CCEL 10-14-2025
- Dividend Yield
- PEPG N/A
- CCEL 13.39%
- EPS Growth
- PEPG N/A
- CCEL N/A
- EPS
- PEPG N/A
- CCEL N/A
- Revenue
- PEPG N/A
- CCEL $31,988,783.00
- Revenue This Year
- PEPG N/A
- CCEL $1.75
- Revenue Next Year
- PEPG N/A
- CCEL N/A
- P/E Ratio
- PEPG N/A
- CCEL N/A
- Revenue Growth
- PEPG N/A
- CCEL 1.10
- 52 Week Low
- PEPG $0.88
- CCEL $4.09
- 52 Week High
- PEPG $10.15
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- PEPG 50.90
- CCEL 42.58
- Support Level
- PEPG $1.37
- CCEL $4.09
- Resistance Level
- PEPG $1.38
- CCEL $4.84
- Average True Range (ATR)
- PEPG 0.13
- CCEL 0.19
- MACD
- PEPG -0.01
- CCEL -0.07
- Stochastic Oscillator
- PEPG 63.64
- CCEL 29.10
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.